Literature DB >> 26889799

Can Cognitive Behavioral Therapy for Insomnia also treat fatigue, pain, and mood symptoms in individuals with traumatic brain injury? - A multiple case report.

William Lu1, Jason W Krellman2, Marcel P Dijkers2.   

Abstract

BACKGROUND: Individuals with traumatic brain injury (TBI) often develop sleep disorders post-injury. The most common one is insomnia, which can exacerbate other post-injury symptoms, including fatigue, impaired cognition, depression, anxiety, and pain. Cognitive Behavioral Therapy for Insomnia (CBT-I) is a manualized treatment that effectively treats insomnia with secondary effects on cognition, mood, and pain in various populations.
OBJECTIVE: This paper reviews the use of CBT-I for three participants with TBI of different severities.
METHODS: Pre- and post-treatment assessments of insomnia, fatigue, depression, anxiety, and pain were conducted. Mood was further assessed at follow-up. Minimal clinically important difference (MCID) scores derived from the research literature were used to establish clinically meaningful symptom improvement on self-report questionnaires.
RESULTS: The reduction in insomnia severity scores for all three participants were not large enough to be considered a clinically significant improvement following CBT-I, although trends toward improvement were observed. However, all participants showed clinically significant reductions in anxiety at post-treatment; the effects persisted for 2 participants at follow-up. Reductions in depression symptoms were observed for 2 participants at post-treatment, and treatment effects persisted for 1 participant at follow-up. One participant endorsed clinically significant improvements in fatigue and pain severity.
CONCLUSIONS: We conclude that CBT-I may provide secondary benefits for symptoms commonly experienced by individuals with TBI, especially mood disturbances.

Entities:  

Keywords:  Insomnia; case study; cognitive behavioral therapy; traumatic brain injury

Mesh:

Year:  2016        PMID: 26889799     DOI: 10.3233/NRE-151296

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  6 in total

1.  Anxiety and Mood Clinical Profile following Sport-related Concussion: From Risk Factors to Treatment.

Authors:  Natalie Sandel; Erin Reynolds; Paul E Cohen; Brandon L Gillie; Anthony P Kontos
Journal:  Sport Exerc Perform Psychol       Date:  2017-06-26

Review 2.  Advocacy for Change: An Osteopathic Review of Traumatic Brain Injury Among Combat Veterans.

Authors:  Gehan A Pendlebury; Peter Oro; William Haynes; Thomas R Byrnes; James Keane; Leonard Goldstein
Journal:  Cureus       Date:  2022-05-16

3.  Factors associated with the remission of insomnia after traumatic brain injury: a traumatic brain injury model systems study.

Authors:  Anthony H Lequerica; Erica Weber; Marcel P Dijkers; Kristen Dams-O'Connor; Stephanie A Kolakowsky-Hayner; Kathleen R Bell; Tamara Bushnik; Yelena Goldin; Flora M Hammond
Journal:  Brain Inj       Date:  2019-10-22       Impact factor: 2.167

4.  A blended eHealth intervention for insomnia following acquired brain injury: study protocol for a randomized controlled trial.

Authors:  Marthe E Ford; Gert J Geurtsen; Erny Groet; Coen A M Van Bennekom; Eus J W Van Someren
Journal:  Trials       Date:  2020-10-16       Impact factor: 2.279

5.  Effects of Cognitive Behavioral Therapy on Pain and Sleep in Adults with Traumatic Brain Injury: A Systematic Review and Meta-Analysis.

Authors:  Xin Li; Yuwei Feng; Jianping Xia; Xuan Zhou; Nan Chen; Zhengquan Chen; Qimeng Fan; Hong Wang; Peiyuan Ding; Qing Du
Journal:  Neural Plast       Date:  2021-11-11       Impact factor: 3.599

6.  The Prevalence and Stability of Sleep-Wake Disturbance and Fatigue throughout the First Year after Mild Traumatic Brain Injury.

Authors:  Simen Berg Saksvik; Migle Karaliute; Håvard Kallestad; Turid Follestad; Robert Asarnow; Anne Vik; Asta Kristine Håberg; Toril Skandsen; Alexander Olsen
Journal:  J Neurotrauma       Date:  2020-07-08       Impact factor: 5.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.